Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/06/2003WO2003014379A3 Improved method and composition for determining resistance to an acetohydroxyacid synthase inhibitor
11/06/2003WO2003012135A3 Method for the configuration of parallel nucleic acid analysis methods for sequence quantity classification
11/06/2003WO2003012124A3 Methods for immobilizing molecules to a solid phase and uses thereof
11/06/2003WO2003010332A3 Test-kit for detecting enterohemorrhagic $i(escherichia coli) strains (ehec)
11/06/2003WO2003009855A3 Organo-phosphorous compounds for activating gamma/delta t cells
11/06/2003WO2003004690A3 Method for isolation of independent, parallel chemical micro-reactions using a porous filter
11/06/2003WO2003003906A3 Diagnostic and screening methods for bladder cancer
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2003001983A3 Methods for diagnosing and treating a disease mediated by decreased mmp-2 function
11/06/2003WO2002101393A3 Method for identifying interaction between proteins and dna fragments of a genome
11/06/2003WO2002101088A3 In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads
11/06/2003WO2002099034A3 Sequences for detection and identification of methicillin-resistant staphyloccocus aureus
11/06/2003WO2002098916A3 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
11/06/2003WO2002083903A3 West nile virus epitopes and uses thereof
11/06/2003WO2002082043A3 Transgenic zebrafish models for neurodegenerative diseases
11/06/2003WO2002081740A8 Supported double-layer structure for displaying a nucleic acid associated with a protein
11/06/2003WO2002079507A3 Method for specifically detecting, isolating and characterizing cells from body samples by transfecting nucleic acid constructs
11/06/2003WO2002079258A3 Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
11/06/2003WO2002077200A3 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
11/06/2003WO2002076482B1 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
11/06/2003WO2002075317A3 Screening for drugs against disorders associated with schizophrenia
11/06/2003WO2002073207A3 Isolated ductal fluid sample
11/06/2003WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002066984A8 Arrays for determining binding of biomolecules
11/06/2003WO2002063048B1 Methods for predicting sensitivity of tumors to arginine deprivation
11/06/2003WO2002062945A3 Compositions and methods relating to lung specific genes and proteins
11/06/2003WO2002062942A3 Filtration assembly
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002061070A8 Environmentally regulated genes, involved in the virulence of streptococcus suis
11/06/2003WO2002059558A8 Means and methods for treatment evaluation
11/06/2003WO2002059371A3 Genome-wide location and function of dna binding proteins
11/06/2003WO2002059352A3 Methods and means for detecting enzymatic cleavage and linkage reactions
11/06/2003WO2002059348A3 Methods for determining the genetic affinity of microorganisms and viruses
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002057489A3 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
11/06/2003WO2002057485A3 Method for analysing nucleic acids based on competitive hybridization
11/06/2003WO2002057469A8 Modulating developmental transitions in plants
11/06/2003WO2002056013A3 Oxazolidinone photoaffinity probes, uses and compounds
11/06/2003WO2002055740A3 Method for detecting disease associated mutations by means of primer extension
11/06/2003WO2002055732A3 Mdt(a), a new efflux protein conferring multiple antibiotic resistance, and uses therefor
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002052035A3 Methods for identification of inhibitors of cinnamyl alcohol dehydrogenase in plants
11/06/2003WO2002046475A3 Method of detecting and treating tuberous sclerosis complex associated disorders
11/06/2003WO2002046465A3 Method for identification of genes involved in specific diseases
11/06/2003WO2002044413A3 Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002040719A3 Retinoid pathway assays, and compositions therefrom
11/06/2003WO2002031190A3 Methods of identification and isolation of polynucleotides containing nucleic acid differences
11/06/2003WO2002027031A3 Methods and reagents for live-cell gene expression quantification
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2002024750A3 Human kidney tumor overexpressed membrane protein 1
11/06/2003WO2002022138A9 Antibacterial agents and methods of identification
11/06/2003WO2002018643A9 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/06/2003WO2002010746A3 Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
11/06/2003WO2002006828A8 Hemoglobin sensor
11/06/2003WO2002006788A8 Electrochemical method for measuring chemical reaction rates
11/06/2003WO2002004952A3 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
11/06/2003WO2000026247A8 Ikaros isoforms and mutants
11/06/2003WO2000023569A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003US20030208780 Useful in preparing recombinant cells for diagnosis and therapy of human tumors
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208041 Chloride channel polypeptides and nucleic acids, and their uses in obtaining compounds for preventing or treating a tick infestation
11/06/2003US20030207885 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
11/06/2003US20030207839 Antisense modulation of Jagged 2 expression
11/06/2003US20030207835 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
11/06/2003US20030207828 DNA whose expression level fluctuates in leukocytes of IgA nephropathy patients in comparison with leukocytes of healthy persons, a process for isolating the DNA, a novel protein encoded by the DNA, an antibody recognizing the protein,
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
11/06/2003US20030207792 Screening for effective agents for the treatment of cancer which method comprises testing a putative agent that is likely to disrupt a critical normal gene product present in said cancer for its cytotoxic and/or growth inhibitory effect
11/06/2003US20030207447 Used to distinguish between arterial endothelial cells (arteries) and venous endothelial cells (veins)
11/06/2003US20030207446 Infectious papillomavirus pseudoviral particles
11/06/2003US20030207434 Phosphodiesterases
11/06/2003US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207426 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207425 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207423 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207422 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207421 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207420 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207418 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207417 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207416 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207415 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207414 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207399 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207397 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207396 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207395 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207390 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207389 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207388 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207387 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207386 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207385 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
1 ... 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 ... 3003